The company at a glance
The company at a glance
SenzaGen’s tests contribute to safer and more sustainable products and to better production environments for employees, while also reducing the number of animal tests.
SenzaGen’s financial objective is to reach breakeven by 2022. To achieve the objective, SenzaGen works in line with the following strategic initiatives:
• Drive GARD®revenue growths
• Broaden our offering
• Develop strategic partnerships
• Ensure regulatory acceptance
• Ensure the right capabilities and resources
• Optimize and adapt internal processes, systems, and tools
The skin-related in vitro toxicology testing market is global, and SenzaGen estimates its current addressable market at approximately SEK 5 billion.
The emergence of allergic disease is on the rise around the world.
By testing the health impact of chemical substances before they are used in cosmetics, colors, cleaning products, and other products, they can be replaced with safer substances, thus reducing clinical symptoms.
The GARD method is an in vitro test based on a human dendritic-like cell line, a set of genes and a prediction model developed using machine learning technology. By utilizing advanced processing tools in combination with high information genomic data, SenzaGen provides a test method with a better predictive accuracy than today’s animal-based methods.
The accuracy for our GARDskin test method is 94% while the equivalent number for animal testing is 75%.*
*) Validation study, OECD Test Guideline Program (TGP no. 4.106). Johansson H. et al. Toxicological Sciences 2019.
Test to determine the dose at which a chemical causes allergy.
Test to determine whether a material causes skin allergies.
Test to determine whether a chemical causes skin allergies.
Test to determine whether a chemical causes respiratory allergies.
Test to classify a chemical’s allergenicity as strong or weak under REACH and CLP. Used in conjunction with GARDskin.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
|cookielawinfo-checkbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checkbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.